Regeneration.
Organized.

We are a pioneering biotechnology company dedicated to producing innovative solutions to treat traumatic nerve injury. With a focus on innovation and collaboration, we develop cutting edge bioprinting solutions and implantable medical devices to improve lives worldwide.

Markets

NeuroSpan Bridge

Peripheral Nerve Injury

Learn more
Auxilium Microfabrication Platform-2

In-Space Biomanufacturing

COMING SOON

Recent News

Dec 16, 2025

Bioprinting & Tissue Engineering Devices Market PDF Report 2025-2033 | Led by North America share of 42.87% in 2024

Auxilium Biotechnologies demonstrated space‐based bioprinting on the ISS in February 2025, successfully printing eight implantable medical devices in microgravity in two hours, highlighting new manufacturing modalities...

May 22, 2025

Auxilium Enrolls First Patient in NeuroSpan Bridge Trial for Nerve Regeneration

Auxilium Biotechnologies has enrolled the first patient in its clinical trial evaluating the safety and efficacy of a device designed to improve nerve regeneration...

May 22, 2025

Auxilium Biotechnologies Launches Clinical Trial for Nerve Regeneration Medical Device

Auxilium Biotechnologies, a leader in regenerative medicine, is pleased to announce the enrollment of the first patient in its clinical trial evaluating the safety and efficacy of NeuroSpan Bridge™, an innovative investigational device designed to improve nerve regeneration...

Mar 6, 2025

Ahead of Crew Return, NASA’s Crew-9 Concludes Science Mission

NASA astronaut Butch Wilmore works with hardware for InSPA Auxilium Bioprinter, a study that tests 3D printing of an implantable medical device that could facilitate recovery from peripheral nerve damage, a type of injury that can cause sensory and motor issues...

Feb 5, 2025

Auxilium Biotechnologies Successfully Prints Medical Devices for the First Time on the International Space Station

This historic achievement showcases the potential of space-based bioprinting to create advanced medical solutions for Earth and future space missions...

Apr 15, 2022

NASA Selects Proposals to Enable Manufacturing In Space for Earth

Auxilium Biotechnologies has been selected for its proposal to develop a second-generation drug-delivery medical device to more effectively treat people who have sustained traumatic peripheral nerve injury...

Media Inquires

Daniel Delson
Daniel@magnitude-growth.com

Contact Us

info@AuxiliumBio.com

(818) 854-0049

Follow Us